In an “historic turning point,” the Trump administration has taken bold action to bring America’s pharmaceutical manufacturing back to the U.S. from China and India.
“Seeking to secure the nation’s supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation’s first strategic stockpile of key ingredients needed to make medicines,” NBC News reported. “The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia.”
More: https://www.dailywire.com/news/trum...tical-manufacturing-out-of-china-back-to-u-s/
“Seeking to secure the nation’s supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation’s first strategic stockpile of key ingredients needed to make medicines,” NBC News reported. “The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia.”
More: https://www.dailywire.com/news/trum...tical-manufacturing-out-of-china-back-to-u-s/
